Literature DB >> 15879160

Hepatocellular carcinoma associated with acquired von Willebrand disease and extreme thrombocytosis.

C-C Chen, J-Y Chang, K-J Liu, C Chan, C-H Ho, S-C Lee, L-T Chen.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15879160     DOI： 10.1093/annonc/mdi171

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  6 in total

1.  Impact of pretreatment hematologic profile on survival of colorectal cancer patients.

Authors:  Miao-zhen Qiu; Zhong-yu Yuan; Hui-yan Luo; Dan-yun Ruan; Zhi-qiang Wang; Feng-hua Wang; Yu-hong Li; Rui-hua Xu
Journal:  Tumour Biol       Date:  2010-03-25

2.  Prognostic significance of a pretreatment hematologic profile in patients with head and neck cancer.

Authors:  Ming-Huang Chen; Peter Mu-Hsin Chang; Po-Min Chen; Cheng-Hwai Tzeng; Pen-Yuan Chu; Shyue-Yih Chang; Muh-Hwa Yang
Journal:  J Cancer Res Clin Oncol       Date:  2009-06-24       Impact factor: 4.553

Review 3.  Thrombocytosis in the NICU.

Authors:  David J Powner; W Keith Hoots
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

4.  Thrombocytosis and hepatocellular carcinoma.

Authors:  Brian I Carr; Vito Guerra
Journal:  Dig Dis Sci       Date:  2013-01-12       Impact factor: 3.199

5.  Platelet Function Tests and Inflammatory Markers for the Differentiation of Primary Thrombocytosis and Secondary Thrombocytosis.

Authors:  Piyapong Kanya; Ekarat Rattarittamrong; Ornkamon Wongtakan; Thanawat Rattanathammethee; Chatree Chai-Adisaksopha; Adisak Tantiworawit; Lalita Norrasethada
Journal:  Asian Pac J Cancer Prev       Date:  2019-07-01

Review 6.  The Intriguing Connections between von Willebrand Factor, ADAMTS13 and Cancer.

Authors:  Chanukya K Colonne; Emmanuel J Favaloro; Leonardo Pasalic
Journal:  Healthcare (Basel)       Date:  2022-03-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.